B dot Medical Inc. (BDM), a leader in ultra-compact proton therapy technology, announced the signing of a Memorandum of Understanding (MOU) with Heron Neutron Medical Corp. (Heron; Taiwan), an innovator in Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT). This strategic partnership aims to explore opportunities to accelerate market penetration, integrate cutting-edge technologies, and streamline cross-border regulatory pathways to establish next-generation particle therapy solutions across Japan, Taiwan, and the broader markets.
- Market expansion across Asia
- Establishment of next-generation particle therapy centers
- Technological exchange of advanced medical equipment
- Mutual support for regulatory approvals in Japan and Taiwan
Proton therapy and Boron Neutron Capture Therapy (BNCT) constitute two of the most advanced modalities in high-precision radiotherapy. Since they operate on fundamentally different mechanisms of action, they possess a distinct division of roles and a mutually complementary relationship across their clinical indications. While proton therapy utilizes the physical precision of the Bragg Peak to spare healthy tissue, BNCT leverages a tumor-targeted boron drug combined with a low-energy neutron beam to destroy cancer cells at a cellular level.
By co-locating these systems, medical centers can provide an unprecedented spectrum of advanced particle care. B dot Medical’s proprietary superconducting magnet technology allows its proton therapy system to be deployed in remarkably limited spaces, making the physical integration with Heron’s AB-BNCT system highly viable for both retrofits and new hospital constructions.
On the institutional and regulatory front, B dot Medical and Heron have established robust medical device quality management systems and obtained ISO certification in Japan and Taiwan, respectively. This partnership is expected to serve as a vital foundation to accelerate the international market expansion of both companies and significantly streamline the regulatory approval processes.
Through strategic and multi-layered collaboration spanning market development, technology, and regulatory affairs, the two companies are poised to drive a new wave of growth in the global particle therapy sector, opening up further possibilities for precision cancer care.
・About Heron Neutron Medical Corp.
Heron Neutron Medical Corp. is a leading developer of advanced boron neutron capture therapy (BNCT) systems based in Taiwan. Focused on precision medicine, Heron develops AB-BNCT solutions to provide targeted cancer care.
